Patents by Inventor Sigalit Levi

Sigalit Levi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID STATE FORMS OF SOFOSBUVIR
    Publication number: 20170015696
    Abstract: The present disclosure encompasses solid state forms of Sofosbuvir and pharmaceutical compositions thereof.
    Type: Application
    Filed: February 19, 2015
    Publication date: January 19, 2017
    Inventors: David Perez PALACIOS, Jens GEIER, Judith ARONHIME, Limor TESSLER-SHAMIS, Sigalit LEVI, Siva Rama Krishna MUPPALLA
  • Nilotinib HCl crystalline forms
    Patent number: 8592442
    Abstract: Crystalline forms of Nilotinib HCl are described.
    Type: Grant
    Filed: June 27, 2012
    Date of Patent: November 26, 2013
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Greta Sterimbaum, Sigalit Levi, Adi Yeori, Tamas Koltai, Valerie Niddam-Hildesheim, Maytal Piran, Shay Asis, Hagit Eisen-Nevo, David Malcolm Crowe
  • NILOTINIB HCL CRYSTALLINE FORMS
    Publication number: 20130096304
    Abstract: Crystalline forms of Nilotinib HCl are described.
    Type: Application
    Filed: June 27, 2012
    Publication date: April 18, 2013
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Greta Sterimbaum, Sigalit Levi, Adi Yeori, Tamas Koltai, Valerie Niddam-Hildesheim, Maytal Piran, Shay Asis, Hagit Eisen-Nevo, David Malcolm Crowe
  • Nilotinib HCl crystalline forms
    Patent number: 8227477
    Abstract: Crystalline forms of Nilotinib HCl are described.
    Type: Grant
    Filed: November 5, 2009
    Date of Patent: July 24, 2012
    Inventors: Greta Sterimbaum, Sigalit Levi, Adi Yeori, Tamas Koltai, Valerie Niddam-Hildesheim, Maytal Piran, Shay Asis, Hagit Eisen-Nevo, David Malcolm Crowe
  • Tigecycline crystalline forms and processes for preparation thereof
    Patent number: 8207361
    Abstract: The present invention relates to solid crystalline Tigecycline, and crystalline forms thereof.
    Type: Grant
    Filed: January 14, 2011
    Date of Patent: June 26, 2012
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Evgeny Tsiperman, Sigalit Levi, Judith Aronhime, Tamas Koltai
  • Crystalline forms of tigecycline and processes for preparation thereof
    Patent number: 8198469
    Abstract: The present invention provides crystalline forms of Tigecycline, and methods of for preparation of crystalline forms and amorphous.
    Type: Grant
    Filed: November 29, 2007
    Date of Patent: June 12, 2012
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Evgeny Tsiperman, Sofia Gorohovsky-Rosenberg, Slavik Yurkovski, Sergei Fine, Tamás Koltai, Sigalit Levi, Leonid Metsger, Michal Rafilovich
  • Crystalline form II of tigecycline and processes for preparation thereof
    Patent number: 8198470
    Abstract: The present invention provides processes for the preparation of crystalline forms of Tigecycline.
    Type: Grant
    Filed: December 1, 2008
    Date of Patent: June 12, 2012
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Sigalit Levi, Michal Rafilovich, Sofia Gorohovsky-Rosenberg, Slavik Yurkovski, Sergei Fine, Leonid Metsger, Evgeny Tsiperman
  • Carvedilol phosphate
    Patent number: 8124644
    Abstract: The invention encompasses novel amorphous and crystalline forms of carvedilol phosphate, carvedilol hydrogen phosphate, and carvedilol dihydrogen phosphate as well as methods of making the novel amorphous and crystalline forms. Also disclosed are pharmaceutical compositions comprising the novel amorphous and crystalline forms and uses thereof.
    Type: Grant
    Filed: May 8, 2009
    Date of Patent: February 28, 2012
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventor: Sigalit Levi
  • SOLID STATES OF ATORVASTATIN POTASSIUM
    Publication number: 20120046335
    Abstract: Atorvastatin potassium crystalline Forms A, B, E, F, and G are provided. Also provided are methods of preparing atorvastatin potassium crystalline Forms A, B, E, F, and G. Atorvastatin potassium crystalline Forms A, B, E, F, and G may be used to prepare pharmaceutical compositions useful for the treatment of hypercholesterolemia or hyperlipidemia.
    Type: Application
    Filed: October 31, 2011
    Publication date: February 23, 2012
    Inventors: Yoav KOWALSKI, Ariel Mittelman, Sigalit Levi
  • Amorphous carvedilol dihydrogen phosphate
    Patent number: 8114900
    Abstract: The invention encompasses novel amorphous and crystalline forms of carvedilol phosphate, carvedilol hydrogen phosphate, and carvedilol dihydrogen phosphate as well as methods of making the novel amorphous and crystalline forms. Also disclosed are pharmaceutical compositions comprising the novel amorphous and crystalline forms and uses thereof.
    Type: Grant
    Filed: May 8, 2009
    Date of Patent: February 14, 2012
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Santiago Ini, Sigalit Levi, Mili Abramov, Eran Turgeman
  • Solid states of atorvastatin potassium
    Patent number: 8071638
    Abstract: Atorvastatin potassium crystalline Forms A, B, E, F, and G are provided. Also provided are methods of preparing atorvastatin potassium crystalline Forms A, B, E, F, and G. Atorvastatin potassium crystalline Forms A, B, E, F, and G may be used to prepare pharmaceutical compositions useful for the treatment of hypercholesterolemia or hyperlipidemia.
    Type: Grant
    Filed: August 6, 2009
    Date of Patent: December 6, 2011
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Yoav Kowalski, Ariel Mittelman, Sigalit Levi
  • Crystal forms of O-desmethylvenlafaxine fumarate
    Patent number: 8063250
    Abstract: Provided are crystalline forms of O-desmethylvenlafaxine fumarate, methods for their preparation, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: November 22, 2011
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Valerie Niddam-Hildesheim, Eli Lancry, Sharona Shachan-tov, Sigalit Levi, Tamar Nidam
  • Carvedilol phosphate
    Patent number: 8022094
    Abstract: The invention encompasses novel amorphous and crystalline forms of carvedilol phosphate, carvedilol hydrogen phosphate, and carvedilol dihydrogen phosphate as well as methods of making the novel amorphous and crystalline forms. Also disclosed are pharmaceutical compositions comprising the novel amorphous and crystalline forms and uses thereof.
    Type: Grant
    Filed: June 28, 2007
    Date of Patent: September 20, 2011
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Santiago Ini, Sigalit Levi, Michal Rafilovich, Judith Aronhime, Mili Abramov, Ron Bar-Shavit, Eran Turgeman
  • TIGECYCLINE CRYSTALLINE FORMS AND PROCESSES FOR PREPARATION THEREOF
    Publication number: 20110112316
    Abstract: The present invention relates to solid crystalline Tigecycline, and crystalline forms thereof.
    Type: Application
    Filed: January 14, 2011
    Publication date: May 12, 2011
    Inventors: Evgeny TSIPERMAN, Sigalit Levi, Judith Aronhime, Tamas Koltai
  • Tigecycline crystalline forms and processes for preparation thereof
    Patent number: 7871993
    Abstract: The present invention relates to solid crystalline Tigecycline, and crystalline forms thereof.
    Type: Grant
    Filed: April 24, 2007
    Date of Patent: January 18, 2011
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Evgeny Tsiperman, Sigalit Levi, Judith Aronhime, Tamas Koltai
  • NILOTINIB HCL CRYSTALLINE FORMS
    Publication number: 20100190812
    Abstract: Crystalline forms of Nilotinib HCl are described.
    Type: Application
    Filed: November 5, 2009
    Publication date: July 29, 2010
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Greta STERIMBAUM, Sigalit LEVI, Adi YEORI, Tamas KOLTAI, Valerie NIDDAM-HILDESHEIM, Maytal PIRAN, Shay ASIS, Hagit Eisen-Nevo, David Malcolm CROWE
  • CRYSTALLINE FORM II OF TIGECYCLINE AND PROCESSES FOR PREPARATION THEREOF
    Publication number: 20100152142
    Abstract: The present invention provides processes for the preparation of crystalline forms of Tigecycline.
    Type: Application
    Filed: December 1, 2008
    Publication date: June 17, 2010
    Inventors: Sigalit Levi, Michal Rafilovich, Sofia Gorohovsky-Rosenberg, Slavik Yurkovski, Sergei Fine, Leonid Metsger, Evgeny Tsiperman
  • Crystal forms of O-desmethylvenlafaxine
    Patent number: 7674935
    Abstract: Methods for preparing crystalline forms of O-desmethylvenlafaxine are described.
    Type: Grant
    Filed: April 17, 2007
    Date of Patent: March 9, 2010
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Sigalit Levi, Valerie Niddam-Hildesheim, Iamas Koltai
  • SOLID STATES OF ATORVASTATIN POTASSIUM
    Publication number: 20100041731
    Abstract: Atorvastatin potassium crystalline Forms A, B, E, F, and G are provided. Also provided are methods of preparing atorvastatin potassium crystalline Forms A, B, E, F, and G. Atorvastatin potassium crystalline Forms A, B, E, F, and G may be used to prepare pharmaceutical compositions useful for the treatment of hypercholesterolemia or hyperlipidemia.
    Type: Application
    Filed: August 6, 2009
    Publication date: February 18, 2010
    Inventors: Yoav KOWALSKI, Ariel Mittelman, Sigalit Levi
  • Novel crystalline forms of armodafinil and preparation thereof
    Publication number: 20090292025
    Abstract: The invention encompasses crystalline forms of armodafinil, processes for preparing the crystalline forms, and pharmaceutical formulation.
    Type: Application
    Filed: June 8, 2009
    Publication date: November 26, 2009
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Viviana Braude, Rinat Moshkovits-Kaptsan, Sigalit Levi